---
title: "LIXTE Biotechnology announces $1.05M registered direct offering; shares fall"
date: "2025-02-11 17:19:51"
summary: "LIXTE Biotechnology (NASDAQ:LIXT) has entered into definitive agreements for the purchase and sale of an aggregate of 434,784 shares of its common stock at $2.415/share, in a registered direct offering. In addition, in a concurrent private placement, the company will issue unregistered warrants to purchase up to an aggregate of..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* LIXTE Biotechnology (NASDAQ:[LIXT](https://seekingalpha.com/symbol/LIXT "Lixte Biotechnology Holdings, Inc.")) has entered into definitive agreements for the purchase and sale of an aggregate of 434,784 shares of its common stock at $2.415/share, in a registered direct offering.
* In addition, in a concurrent private placement, the company will issue unregistered warrants to purchase up to an aggregate of 434,784 shares of common stock.
* The warrants will have an exercise price of $2.29/share and will be exercisable for five years from the date of issuance.
* The closing of the offering is expected to occur on or about February 12, 2025.
* The aggregate gross proceeds to the company from the offering are expected to be ~$1.05M.
* The company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.
* LIXT shares drop nearly 19% premarket on Tuesday.
* Source: [Press release](https://seekingalpha.com/pr/19998184-lixte-biotechnology-announces-1_05-million-registered-direct-offering-priced-at-the-market)

[seekalpha](https://seekingalpha.com/news/4406144-lixte-biotechnology-announces-105m-registered-direct-offering-shares-fall)
